Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Eight-year clinical outcomes of long-term enzyme replacement therapy for 884 children with Gaucher disease type 1.

Andersson H, Kaplan P, Kacena K, Yee J.

Pediatrics. 2008 Dec;122(6):1182-90. doi: 10.1542/peds.2007-2144.

PMID:
19047232
2.

Velaglucerase alfa for the management of type 1 Gaucher disease.

Morris JL.

Clin Ther. 2012 Feb;34(2):259-71. doi: 10.1016/j.clinthera.2011.12.017. Epub 2012 Jan 20. Review.

PMID:
22264444
3.

Response of Gaucher bone disease to enzyme replacement therapy.

Poll LW, Maas M, Terk MR, Roca-Espiau M, Bembi B, Ciana G, Weinreb NJ.

Br J Radiol. 2002;75 Suppl 1:A25-36. Review.

PMID:
12036830
4.

The female Gaucher patient: the impact of enzyme replacement therapy around key reproductive events (menstruation, pregnancy and menopause).

Zimran A, Morris E, Mengel E, Kaplan P, Belmatoug N, Hughes DA, Malinova V, Heitner R, Sobreira E, Mrsić M, Granovsky-Grisaru S, Amato D, vom Dahl S.

Blood Cells Mol Dis. 2009 Nov-Dec;43(3):264-88. doi: 10.1016/j.bcmd.2009.04.003. Epub 2009 Jun 6. Review.

PMID:
19502088
5.

Individualization of long-term enzyme replacement therapy for Gaucher disease.

Andersson HC, Charrow J, Kaplan P, Mistry P, Pastores GM, Prakash-Cheng A, Rosenbloom BE, Scott CR, Wappner RS, Weinreb NJ; International Collaborative Gaucher Group U.S. Regional Coordinators.

Genet Med. 2005 Feb;7(2):105-10. Review. Erratum in: Genet Med. 2005 Sep;7(7):514. Prakesh-Cheng, Ainu [corrected to Prakash-Cheng, Ainu]. Genet Med. 2005 Jul-Aug;7(6):460.

PMID:
15714077
6.

Bone complications in children with Gaucher disease.

Bembi B, Ciana G, Mengel E, Terk MR, Martini C, Wenstrup RJ.

Br J Radiol. 2002;75 Suppl 1:A37-44. Review.

PMID:
12036831
7.

Alglucerase. A review of its therapeutic use in Gaucher's disease.

Whittington R, Goa KL.

Drugs. 1992 Jul;44(1):72-93. Review.

PMID:
1379912
8.

Gaucher's disease: a review.

Morales LE.

Ann Pharmacother. 1996 Apr;30(4):381-8. Review.

PMID:
8729893
9.

Alglucerase. A pharmacoeconomic appraisal of its use in the treatment of Gaucher's disease.

Whittington R, Goa KL.

Pharmacoeconomics. 1995 Jan;7(1):63-90. Review.

PMID:
10155294
10.

Revised recommendations for the management of Gaucher disease in children.

Kaplan P, Baris H, De Meirleir L, Di Rocco M, El-Beshlawy A, Huemer M, Martins AM, Nascu I, Rohrbach M, Steinbach L, Cohen IJ.

Eur J Pediatr. 2013 Apr;172(4):447-58. doi: 10.1007/s00431-012-1771-z. Epub 2012 Jul 8. Review.

PMID:
22772880
11.

Management of Gaucher disease: enzyme replacement therapy.

Zimran A, Elstein D.

Pediatr Endocrinol Rev. 2014 Sep;12 Suppl 1:82-7. Review.

PMID:
25345089
12.

[Osteoarticular manifestations of Gaucher disease in adults: pathophysiology and treatment].

Javier RM, Hachulla E.

Presse Med. 2007 Dec;36(12 Pt 3):1971-84. Epub 2007 May 10. Review. French.

13.

Therapeutic approaches to bone pathology in Gaucher disease: past, present and future.

Goker-Alpan O.

Mol Genet Metab. 2011 Dec;104(4):438-47. doi: 10.1016/j.ymgme.2011.08.004. Epub 2011 Aug 11. Review.

14.

Imiglucerase in the management of Gaucher disease type 1: an evidence-based review of its place in therapy.

Serratrice C, Carballo S, Serratrice J, Stirnemann J.

Core Evid. 2016 Oct 14;11:37-47. eCollection 2016. Review.

15.

Recommendations for the use of eliglustat in the treatment of adults with Gaucher disease type 1 in the United States.

Balwani M, Burrow TA, Charrow J, Goker-Alpan O, Kaplan P, Kishnani PS, Mistry P, Ruskin J, Weinreb N.

Mol Genet Metab. 2016 Feb;117(2):95-103. doi: 10.1016/j.ymgme.2015.09.002. Epub 2015 Sep 7. Review.

16.

Imiglucerase in the treatment of Gaucher disease: a history and perspective.

Deegan PB, Cox TM.

Drug Des Devel Ther. 2012;6:81-106. doi: 10.2147/DDDT.S14395. Epub 2012 Apr 18. Review.

17.

Imaging of Gaucher disease.

Simpson WL, Hermann G, Balwani M.

World J Radiol. 2014 Sep 28;6(9):657-68. doi: 10.4329/wjr.v6.i9.657. Review.

18.

Management and monitoring recommendations for the use of eliglustat in adults with type 1 Gaucher disease in Europe.

Belmatoug N, Di Rocco M, Fraga C, Giraldo P, Hughes D, Lukina E, Maison-Blanche P, Merkel M, Niederau C, Plӧckinger U, Richter J, Stulnig TM, Vom Dahl S, Cox TM.

Eur J Intern Med. 2017 Jan;37:25-32. doi: 10.1016/j.ejim.2016.07.011. Epub 2016 Aug 10. Review.

Supplemental Content

Support Center